In a world first, youngest child undergoes own cord blood reinfusion to determine potential to prevent or delay onset of Type 1 Diabetes
As part of The CORD study (Cord Reinfusion in Diabetes), Lucy, a 20 month old Australian girl, was reinfused with her own umbilical cord blood to determine whether it will delay or prevent the onset of type 1 diabetes. The study is being conducted through the Kids...
Canadian Company Initiates Clinical Trial Using an Expanded Cord Blood for Acute Myeloid Leukemia (AML)
Research Update- AML Trial ExCellThera is a clinical stage biotech company that is focused on developing a robust and cost effective technology to expand blood stem cells from cord blood for therapeutic use. ExCellThera is a spin-off company from the Institute for...
Update: Cerebral Palsy and Cord Blood Clinical Trials
Update on clinical trials investigating cord blood as a treatment of cerebral palsy Over the past few years, a number of clinical trials have been initiated to investigate whether cord blood (CB) could be used in the treatment of cerebral palsy (CP). The rationale...
Ontario leads in Stem Cell Clinical Trials for Spinal Cord Injuries
In recent years, the list of diseases and conditions being studied in clinical trials has grown exponentially. While, 10 years ago, the announcement of a stem cell clinical trial for a condition other than cancer would have been revolutionary, this year alone, Ontario...
